İntraoküler tümörler, glokomun nadir sebepleri arasında olsa da sebebi açıklanamayan glokom hastalarında mutlaka düşünülmelidir. Benign, malign, primer veya metastatik intraoküler tümörler nedeni ile glokom oluşabilmektedir. Tanıda ve tedavide ortaya çıkan zorluklar nedeni ile intraoküler tümörlerin glokom ile ilişkisi bilinmelidir. Glokom gelişen hastalarda oluşum mekanizması, tedavi ve prognoz tümörün tipine ve yerleşim yerine göre farklılıklar göstermektedir. Literatür incelendiğinde; daha sıklıkla melanoma, melanositoma, iris nevüsleri, retinoblastoma, medulloepitelyoma, juvenil ksantogranüloma, lösemi, lenfoma, metastatik tümörler, Sturge Weber Sendromu ve Nörofibromatozis nedeni ile oluşan glokom hastaları tanımlanmıştır. Patofizyolojide açıya direkt invazyon, pigment dispersiyonu, melanofajik, hemolitik, üveitik, açı kapanması, neovaskülarizasyon, hemoraji, iris lens diyaframının anterior deplasmanı gibi birçok mekanizma yer almaktadır. İntraoküler tümörlerin kendisi glokoma neden olabileceği gibi, tümöre yönelik tedavi de glokoma sebep olabilir. Tümörleri her zaman biyomikroskobik inceleme ile tanımak mümkün değildir. Tanıya yardımcı olarak ön segment optik kohorens tomografi, ultrasonik biyomikroskopi ve radyolojik tetkikler (BT/MR/PET-BT) de kullanılmaktadır. Tedavide farmakolojik ajanlar, lazer, cerrahi girişimler, intravitreal anti-vasküler endotelyal büyüme faktörü uygulaması ve radyoterapi ele alınmıştır. Bu çalışmada, konu ile ilgili literatür göz önünde bulundurularak, intraoküler tümörlerin glokom oluşturma mekanizmaları anlatılıp tanıda kullanılan tetkikler ve tedavide izlenecek stratejiler incelenmiştir. Doğru tanı ve tedavi ile intraoküler tümör nedeni ile oluşan glokom hastalarında hem görme düzeylerinin korunması hem de yaşam süresinin uzatılması amaçlanmaktadır.
Anahtar Kelimeler: Onkoloji; neovaskülarizasyon; glokom
Intraocular tumors are rare causes of glaucoma, and in cases of unexplained glaucoma, the possibility of an intraocular tumor must be considered. Glaucoma is associated with benign, malign, primary and metastatic intraocular tumors. Because of the difficulties in diagnosis and treatment, the relation between intraocular tumors and glaucoma should be known. Mechanism of glaucoma, treatment options and prognosis varies according to tumor type and location. In the literature, glaucoma due to melanoma, melanocytoma, iris nevi, retinoblastoma, medulloepithelioma, juvenil xanthogranuloma, leukemia, lymphoma, metastatic tumors, Sturge Weber syndrome and neurofibromatosis have been described. There are many mechanisms such as direct invasion to angle, pigment dispersion, melanophagic, hemolytic, uveitic, angle closure, neovascularization, hemorrhage, anterior displacement of iris lens diaphragm in pathophysiology. Treatment of intraocular tumors can also cause secondary glaucoma. Tumors are not always able to be recognized by examination. Anterior segment Optic Cohorence Tomography, ultrasonic biomicroscopy, and radiological imaging can be use to diagnose. Pharmacological agents, laser, surgical interventions intravitreal antivascular endothelial growth factor enjection and radiotherapy for treatment are discussed. In this review, the mechanism of glaucoma secondary to intraocular tumors, diagnostic tecniques and treatment options are discussed by considering the related literature. The aim is to protect both the visual acuity and the life expectancy of the patients in glaucoma cases caused by intraocular tumor with correct diagnosis and treatment.
Keywords: Oncology; neovascularization; glaucoma
- Shields CL, Shields JA, Shields MB, Augsburger JJ. Prevalence and mechanisms of secondary intraocular pressure elevation in eyes with intraocular tumors. Ophthalmology. 1987;94(7):839-46. [Crossref]
- Foulds WS, Lee WR. The significance of glaucoma in the management of melanomas of the anterior segment. Trans Ophthalmol Soc U K. 1983;103(Pt 1):59-63.
- Shields CL, Materin MA, Shields JA, Gershenbaum E, Singh AD, Smith A. Factors associated with elevated intraocular pressure in eyes with iris melanoma. Br J Ophthalmol. 2001;85(6):666-9. [Crossref] [PubMed] [PMC]
- Demirci H, Shields CL, Shields JA, Eagle RC Jr, Honavar SG. Diffuse iris melanoma: a report of 25 cases. Ophthalmology. 2002;109(8):1553-60. [Crossref]
- Yanoff M. Glaucoma mechanisms in ocular malignant melanomas. Am J Ophthalmol. 1970;70(6):898-904. [Crossref]
- Yanoff M, Scheie HG. Melanomalytic glaucoma. Report of a case. Arch Ophthalmol. 1970;84(4):471-3. [Crossref] [PubMed]
- Van Buskirk EM, Leure-duPree AE. Pathophysiology and electron microscopy of melanomalytic glaucoma. Am J Ophthalmol. 1987;85(2):160-6. [Crossref]
- el Baba F, Hagler WS, De la Cruz A, Green WR. Choroidal melanoma with pigment dispersion in vitreous and melanomalytic glaucoma. Ophthalmology. 1988;95(3):370-7. [Crossref]
- Kuchle M, Tiemann M, Holbach L, Naumann GO. Necrotic malignant melanoma of the choroid and concurrent intraocular manifestation of malignant non-Hodgkin's B cell lymphoma. Ophthalmologica. 1994;208(2):65-70. [Crossref] [PubMed]
- Tantri A, Alward WLM, Weingeist TA. Iris melanoma: 47 yo manreferred in 1997 for evaluation of iris lesion OS. EyeRounds.org; 2005.
- Shields JA, Shields CL, Kiratli H, de Potter P. Metastatic tumors to the iris in 40 patients. Am J Ophthalmol. 1995;119(4):422-30. [Crossref]
- Ferry AP, Font RL. Carcinoma metastatic to the eye and orbit II. A clinicopathological study of 26 patients with carcinoma metastatic to the anterior segment of the eye. Arch Ophthalmol. 1975;93(7):472-82. [Crossref] [PubMed]
- Finger PT, Harbour JW, Karcioglu ZA. Risk factors for metastasis in retinoblastoma. Surv Ophthalmol. 2002;47(1):1-16. [Crossref]
- Stafford WR, Yanoff M, Parnell BL. Retinoblastomas initially misdiagnosed as primary ocular inflammations. Arch Ophthalmol. 1969;82(6):771-3. [Crossref] [PubMed]
- Pe'er J, Neufeld M, Baras M, Gnessin H, Itin A, Keshet E. Rubeosis iridis in retinoblastoma. Histologic findings and the possible role of vascular endothelial growth factor in its induction. Ophthalmology. 1997;104(8):1251-8. [Crossref]
- Shields MB, Proia AD. Neovascular glaucoma associated with an iris melanoma. A clinicopathologic report. Arch Ophthalmol. 1987;105(5):672-4. [Crossref] [PubMed]
- Demirci H, Mashayekhi A, Shields CL, Eagle RC Jr, Shields JA. Iris melanocytoma: clinical features and natural course in 47 cases. Am J Ophthalmol. 2005;139(3):468-75. [Crossref] [PubMed]
- Yi DH, Rashid S, Cibas ES, Arrigg PG, Dana MR. Acute unilateral leukemic hypopyon in an adult with relapsing acute lymphoblastic leu-kemia. Am J Ophthalmol. 2005;139(4):719-21. [Crossref] [PubMed]
- Velez G, de Smet MD, Whitcup SM, Robinson M, Nussenblatt RB, Chan CC. Iris involvement in primary intraocular lymphoma: report of two cases and review of the literature. Surv Ophthalmol. 2000;44(6):518-26. [Crossref]
- Raju VK, Green WR. Reticulum cell sarcoma of the uvea. Ann Ophthalmol. 1982;14(6):555-60.
- Baker TR, Spencer WH. Ocular findings in multiple myeloma. A report of two cases. Arch Ophthalmol. 1974;91(2):110-3. [Crossref] [PubMed]
- Maisel JM, Miller F, Sibony PA, Maisel LM. Multiple myeloma presenting with ocular inflammation. Ann Ophthalmol. 1987;19(5):170-4.
- Treacy KW, Letson RD, Summers CG. Subconjunctival steroid in the management of uveal juvenile xanthogranuloma: a case report. J Pediatr Ophthalmol Strabismus.1990;27(3):126-8.
- Sullivan TJ, Clarke MP, Morin JD. The ocular manifestations of the Sturge-Weber syndrome. J Pediatr Ophthalmol Strabismus. 1992;29(6):349-56.
- Phelps CD. The pathogenesis of glaucoma in Sturge-Weber syndrome. Ophthalmology. 1978;85(3):276-86. [Crossref]
- Thavikulwat AT, Edward DP, AlDarrab A, Vajaranant TS. Pathophysiology and management of glaucoma associated with phakomatoses. J Neurosci Res. 2019;97(1):57-69. [Crossref] [PubMed]
- Morales J, Chaudhry IA, Bosley TM. Glaucoma and globe enlargement associated with neurofibromatosis type 1. Ophthalmology. 2009;116(9):1725-30. [Crossref] [PubMed]
- Spraul CW, Grossniklaus HE. Vitreous hemorrhage. Surv Ophthalmol. 1997;42(1):3-39. [Crossref]
- Lieb WE, Shields JA, Shields CL, Spaeth GL. Mucinous adenocarcinoma metastatic to the iris, ciliary body, and choroid. Br J Ophthalmol. 1990;74(6):373-6. [Crossref] [PubMed] [PMC]
- Finger PT. Radiation therapy for choroidal melanoma. Surv Ophthalmol. 1997;42(3):215-32. [Crossref]
- Tuncer S. [Brachytherapy in the management of uveal melanomas]. Turkish J Ophthalmol. 2014;44(Ozel):43-8.
- Janssens K, Mertens M, Lauwers N, de Keizer RJ, Mathysen DG, De Groot V. To study and determine the role of anterior segment optical coherence tomography and ultrasound biomicroscopy in corneal and conjunctival tumors. J Ophthalmol. 2016;2016:1048760. [Crossref] [PubMed] [PMC]
- Girkin CA, Goldberg I, Mansberger SL, Shields JA, Shields CL. Management of iris melanoma with secondary glaucoma. J Glaucoma. 2002;11(1):71-4. [Crossref] [PubMed]
- Grossniklaus HE, Brown RH, Stulting RD, Blasberg RD. Iris melanoma seeding through a trabeculectomy site. Arch Ophthalmol. 1990;108(9):1287-90. [Crossref] [PubMed]
.: Process List